
Resolving the IPR Issue During HFC Phase-down
Multinational corporations (MNCs) have kept the world in a chemical treadmill by selling patented refrigerants. They are now introducing a new patented chemical – HFOs. Should Montreal Protocol pay for transitioning to yet another patented chemical to benefit MNCs?
Reports by Chandra Bhushan














































































































